Abu Dhabi Investment Authority in Ziopharm Oncology Inc
Completed. First disclosed May 12, 2006, in a Schedule 13G (source).
- Investor
- Abu Dhabi Investment Authority (United Arab Emirates)
- Target
- Ziopharm Oncology Inc (EDGAR CIK 1107421)
- Target country
- United States
- Sector
- Health and Life Sciences (SIC 8093)
- First disclosed
- May 12, 2006, Schedule 13G
- Amount
- Not stated
- Stake at first disclosure
- 9.2%
- Latest stated stake
- 3.16% (June 17, 2010)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| May 12, 2006 | Schedule 13G | 9.2% | View |
| May 15, 2006 | Schedule 13G | 9.2% | View |
| June 17, 2010 | Schedule 13G | 3.16% | View |
Cite: Middle East Forum, “Abu Dhabi Investment Authority in Ziopharm Oncology Inc,” Gulf Sovereign Holdings, accessed October 22, 2026, https://statemoney.meforum.org/deal/adia-ziopharm-oncology-inc-1107421/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.